Literature DB >> 11578782

Pathological glial tau accumulations in neurodegenerative disease: review and case report.

R W Berry1, B Quinn, N Johnson, E J Cochran, N Ghoshal, L I Binder.   

Abstract

Abnormal deposits of tau protein accumulate in glia in many neurodegenerative diseases. This suggests that in some instances the disease process may target glial tau, with neuronal degeneration a secondary consequence of this process. In this report, we summarize the pattern of glial tau pathology in various neurodegenerative disorders and add original findings from a case of sporadic frontotemporal dementia that exhibits astrocytic tau pathology. The neurodegenerative diseases span the spectrum of relative neuronal and glial tau involvement, from disorders affecting only neuronal tau to those in which abnormal tau deposits are found only in glia. From this, we conclude that glial tau can be a primary target of the disease process, and that this can lead to neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578782     DOI: 10.1016/s0197-0186(01)00054-7

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Globular glial tauopathies (GGT): consensus recommendations.

Authors:  Zeshan Ahmed; Gabor G Kovacs; Eileen H Bigio; Herbert Budka; Dennis W Dickson; Isidro Ferrer; Bernardino Ghetti; Giorgio Giaccone; Kimmo J Hatanpaa; Janice L Holton; Keith A Josephs; James Powers; Salvatore Spina; Hitoshi Takahashi; Charles L White; Tamas Revesz
Journal:  Acta Neuropathol       Date:  2013-08-31       Impact factor: 17.088

2.  Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy.

Authors:  Kenneth J Colodner; Mel B Feany
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

Review 3.  The power and richness of modelling tauopathies in Drosophila.

Authors:  Katerina Papanikolopoulou; Efthimios M C Skoulakis
Journal:  Mol Neurobiol       Date:  2011-06-17       Impact factor: 5.590

4.  Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.

Authors:  Simona Capsoni; Cecilia Tiveron; Domenico Vignone; Gianluca Amato; Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 5.  Tau-based treatment strategies in neurodegenerative diseases.

Authors:  Anja Schneider; Eckhard Mandelkow
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

6.  A case of globular glial tauopathy presenting clinically as alzheimer disease.

Authors:  Karen S SantaCruz; Sue J Rottunda; Joyce P Meints; Elaine L Bearer; Eileen H Bigio; John Riley McCarten
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

7.  Characterization of Early Pathological Tau Conformations and Phosphorylation in Chronic Traumatic Encephalopathy.

Authors:  Nicholas M Kanaan; Kristine Cox; Victor E Alvarez; Thor D Stein; Sharra Poncil; Ann C McKee
Journal:  J Neuropathol Exp Neurol       Date:  2016-01       Impact factor: 3.685

8.  White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration.

Authors:  Gabor G Kovacs; Katalin Majtenyi; Salvatore Spina; Jill R Murrell; Ellen Gelpi; Romana Hoftberger; Graham Fraser; R Anthony Crowther; Michel Goedert; Herbert Budka; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

9.  Expanding the phenotypic associations of globular glial tau subtypes.

Authors:  James R Burrell; Shelley Forrest; Thomas H Bak; John R Hodges; Glenda M Halliday; Jillian J Kril
Journal:  Alzheimers Dement (Amst)       Date:  2016-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.